Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-056892
Filing Date
2025-06-05
Accepted
2025-06-05 17:01:02
Documents
5
Effectiveness Date
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2517064d1_s8.htm S-8 73918
2 EXHIBIT 5.1 tm2517064d1_ex5-1.htm EX-5.1 8290
3 EXHIBIT 23.2 tm2517064d1_ex23-2.htm EX-23.2 1931
4 EX-FILING FEES tm2517064d1_ex-filingfees.htm EX-FILING FEES 13608
5 GRAPHIC tm2517064d1_ex5-1img001.jpg GRAPHIC 2567
  Complete submission text file 0001104659-25-056892.txt   102488
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287812 | Film No.: 251027933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)